Cytomegalovirus (CMV) infections are among the most common infections that occur
following solid organ transplantation. CMV disease ranges from asymptomatic viremia, to …

The majority of patients who undergo liver transplantation (LT) spend some time in the
intensive care unit during the postoperative period. For some, this is an expected part of the …

The precise impact of valganciclovir as preventive therapy for cytomegalovirus (CMV) in
solid organ transplant (SOT) recipients is not fully defined. Data from studies using …

Primary gastrointestinal cytomegalovirus (CMV) disease after solid organ transplantation
(SOT) is difficult to treat and may relapse. Herein, we reviewed the clinical records of CMV …

Cytomegalovirus (CMV) infection is common worldwide, but the majority are asymptomatic.
However, during initial infection or reactivation, CMV can cause tissue-invasive end-organ …

Cytomegalovirus (CMV) is one of the most common viral pathogens causing clinical disease
in liver transplant recipients, and contributing to substantial morbidity and occasional …

Background. Cytomegalovirus (CMV) disease is the most common infectious complication
after solid organ transplantation, frequently affecting the gastrointestinal (GI) tract. There are …

Cytomegalovirus (CMV) has emerged as a significant opportunistic pathogen in the era of
immunosuppression. CMV was a common cause of gastrointestinal disease in AIDS …

The number of liver transplants (LT) performed worldwide continues to rise, and LT
recipients are living longer post‐transplant. This has led to an increasing number of LT …

Prolonging cytomegalovirus (CMV) prophylaxis in CMV seronegative recipients of a kidney
from CMV seropositive donor (D+/R–) may reduce the incidence of late infections. We …